anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Alkermes · conference-presentation

Alkermes | Results Presentation Deck | 21 slides

21 pages · 4 arc beats · 1 loops

Conference-Presentation Download JSON
Unlock

Alkermes | Results Presentation Deck | 21 slides

Alkermes · 2023-04
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 21 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 3 slides 100% 3/3 slides 100% 3/3 slides · 8 hits
— 0/3 slides
— 0/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides
Need 11 slides 100% 11/11 slides 100% 11/11 slides · 38 hits
— 0/11 slides
27.3% 3/11 slides
— 0/11 slides
100% 11/11 slides
— 0/11 slides
Satisfaction 3 slides 100% 3/3 slides 100% 3/3 slides · 15 hits
— 0/3 slides
66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides Action 4 slides 100% 4/4 slides 100% 4/4 slides · 10 hits
— 0/4 slides
50% 2/4 slides
— 0/4 slides
100% 4/4 slides
— 0/4 slides

Slide inventory

21
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
transition
Open slide detailBeat · Need
05
Includes footnotes regarding non-GAAP reconciliation and royalty revenue impacts from Janssen license agreement.analyze_data
Open slide detailBeat · Need
06
Includes a highlighted column for Q1'23 and detailed footnotes regarding product licensing and arbitration.analyze_data
Open slide detailBeat · Need
07
The slide includes a disclaimer regarding the date of the expectations and a note about non-GAAP reconciliation.analyze_data
Open slide detailBeat · Need
08
front_matter
Open slide detailBeat · Need
09
The chart illustrates the revenue contribution of four products: VIVITROL, ARISTADA, VUMERITY, and LYBALVI.analyze_data
Open slide detailBeat · Need
10
analyze_data
Open slide detailBeat · Need
11
analyze_data
Open slide detailBeat · Need
12
analyze_data
Open slide detailBeat · Need
13
The chart includes a vertical dashed line separating 2021 from 2022.analyze_data
Open slide detailBeat · Need
14
transition
Open slide detailBeat · Need
15
prioritize
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
16
summarize
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
17
The slide outlines a two-stage clinical development strategy with specific objectives and assessment criteria for each phase.plan_implementation
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
18
appendix
Open slide detailBeat · Action
19
appendix
Open slide detailBeat · Action
20
The table reconciles GAAP net loss of $180M to non-GAAP net income of $20M using various non-cash and one-time adjustments.analyze_data
Open slide detailBeat · Action
21
state_next_steps
Open slide detailBeat · Action